News

Two Female Scientists in the US and UK Granted $400K for Promising Lung Cancer Research

 

Media Contact: Diane Mulligan                                                                                   
dmulligan@mandcommunications.com                                                                           
720-273-0927      

Adam Mohrbacher     
IASLC Content Specialist 
adam.mohrbacher@iaslc.org | 720-598-1943                                                                 


Two Female Scientists in the US and UK Granted $400K for Promising Lung Cancer Research

Funding supports search for new treatments for the deadliest form of cancer

Los Angeles, CA (NOV 15, 2016) – More people die from lung cancer every year than any other cancers, and researchers are hard-pressed to find funding for studies that could improve treatments. As November is Lung Cancer Awareness Month, there is hopeful news.

The Lung Cancer Foundation of America (LCFA) and International Association for the Study of Lung Cancer (IASLC) have partnered to fund the Lori Monroe Scholarship for Lung Cancer Research. These $200,000 grants support promising new research led by two female scientists chosen from among 33 worldwide applicants.

  • Carla Martins, PhD with the University of Cambridge in England, will use the funding to study how exploiting the metabolic heterogeneity of mutant KRAS lung tumors can be used to optimize therapy.
  • Kellie Smith, PhD with Johns Hopkins University School of Medicine in Baltimore will focus on neoantigen targeting in patients with early stage non-small-cell lung carcinoma (NSCLC), which accounts for about 85% of all lung cancers.

(from left to right) Kellie Smith, PhD, Johns Hopkins University School of Medicine, and Carla Martins, PhD, University of Cambridge

“The IASLC is proud to join LCFA in providing these grants to two very promising young investigators. These important research projects will hopefully lead to encouraging results benefiting many lung cancer patients,” said Dr. Fred R. Hirsch, MD, PhD, CEO of IASLC.

“The LCFA/IASLC Lori Monroe Scholarship for Lung Cancer Research is the kind of private donor funding that is the lifeline for pioneering researchers like Smith and Martins to conduct their important work to help give lung cancer patients improved treatment options,” said Kim Norris, LCFA President and Co-Founder.

To date, LCFA and IASLC have partnered to fund more than $1 million in research grants.

About the IASLC
The International Association for the Study of Lung Cancer (IASLC) is the only global organization dedicated solely to the study of lung cancer. Founded in 1974, the association's membership includes more than 6,000 lung cancer specialists in over 100 countries. Visit www.iaslc.org for more information.

About the LCFA
LCFA’s mission is the dramatic improvement in survivorship of lung cancer patients through the funding of transformative science, with the ultimate goal of curing the disease. Visit lcfamerica.org for the latest information and to donate.

###

November 15, 2016